Atlas Trials

Pharmacological Modulation of Belief Salience

Clinical trial NCT03754062 · COMPLETED

Trial details

NCT number
NCT03754062
Sponsor
King's College London
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HaloperidolPlaceboL-DOPA
Start date
2017-06-01
Primary completion
2019-09-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.